Early malignant tumors of the upper gastrointestinal tract (esophagus, stomach, and duodenum)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with early malignant tumors of the upper gastrointestinal tract (esophagus, stomach, or duodenum) scheduled to undergo Endoscopic Submucosal Dissection in which the novel anchor ring-shaped thread counter-traction method will be applied. 2. Patients who provide written informed consent. 3. No restrictions on age or sex.
Exclusion criteria
Exclusion criteria: 1. Patients deemed to be at high risk for endoscopic treatment (Endoscopic Submucosal Dissection) due to poor general condition or other clinical factors. 2. Patients who do not provide informed consent for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total procedure time (in minutes) from the start of mucosal incision to completion of lesion resection during Endoscopic Submucosal Dissection assisted by the novel anchor ring-shaped thread counter-traction method. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. R0 resection rate:The proportion of lesions in which the pathological evaluation confirms tumor-free horizontal and vertical margins. 2. Incidence of intraoperative adverse events:Complications occurring during Endoscopic Submucosal Dissection, including perforation and bleeding. 3. Incidence of postoperative adverse events:Adverse events occurring after the procedure, such as delayed bleeding, fever, or abdominal pain. 4. Association between lesion characteristics and procedure time:The relationship between lesion size or location and the procedure time influenced by the traction method. | — |
Countries
Japan
Contacts
Ehime University Graduate School of Medicine Department of Advanced and Innovative Endoscopy